August 20
Myricx Bio Awarded Cancer Research Horizons Start-Up Achievement Recognition Award for 2025
Read more
Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand. We are a unique collaboration between major Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments and more than 50 leading medical research institutes and research hospitals.
Learn more about who we areA clinical stage company developing treatment for hot flashes in cancer survivors undergoing endocrine therapy
View ProjectDeveloping disease-modifying mitochondrial therapeutics for neurodegenerative disorders
View ProjectDeveloping the next generation of CAR-T cell therapies to treat solid cancers
View ProjectCombining non-opioid analgesics and biopolymers to deliver weeks of localised pain management
View ProjectUnlocking the potential of N-myristoyltransferase (NMT) to develop precision medicines for a range of diseases including cancer and viral infections
View ProjectGlyscend is developing novel non-absorbable polymers that are orally-delivered for the treatment of Type 2 Diabetes.
View ProjectCommitted to making the discoveries that will relieve the future burden of disease, the newly established Monash Biomedicine Discovery Institute at Monash University brings together more than 120 internationally-renowned research teams. Our researchers are supported by world-class technology and infrastructure, and partner with industry, clinicians and researchers internationally to enhance lives through discovery.
ViewThe Florey Institute of Neuroscience and Mental Health is one of the largest and highly respected brain research centres in the world.
ViewThe Curtin Health Innovation Research Institute (CHIRI) is dedicated to developing new treatments for diseases that more commonly occur with older age.
ViewBrandon BioCatalyst is innovation in action: We provide a path for taking medical science from conception into the real world.
Our Venture capital model is unique. We don’t simply provide investment, we partner with entrepreneurs to create businesses, run companies and everything necessary to ensure our investments succeed.
Learn moreMyricx Bio Awarded Cancer Research Horizons Start-Up Achievement Recognition Award for 2025
Read moreMIRUGEN SECURES A$4.5M TO PIONEER CELL (RE)PROGRAMMING, AND WELCOMES CHARLOTTE CASEBOURNE STOCK AS EXECUTIVE CHAIR
Read moreBrandon BioCatalyst’s CUREator set to support up to 15 therapeutic biotech’s thanks to funding from the Medical Research Future Fund.
Read more